Circulation. 2001;104:2012-2017
doi: 10.1161/hc4201.097835
doi: 10.1161/hc4201.097835
(Circulation. 2001;104:2012.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease
A Randomized, Double-Blind, Placebo-Controlled Study
From the Swiss Cardiovascular Center Bern, Cardiology, University Hospital, Bern, Switzerland.
Correspondence to Christian Seiler, MD, FACC, FESC, Professor of Cardiology, University Hospital, CH-3010 Bern, Switzerland. E-mail christian.seiler.cardio{at}insel.ch
Background— Experimentally, activated macrophages have been documented to induce vascular proliferation.
Methods and Results— In 21 patients (age 74±9 years) with extensive coronary artery disease not eligible for coronary artery bypass surgery, the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF, Molgramostim) on quantitatively assessed collateral flow was tested in a randomized, double-blind, placebo-controlled fashion. The study protocol consisted of an invasive collateral flow index (CFI) measurement immediately before intracoronary injection of 40 µg of GM-CSF (n=10) or placebo (n=11) and after a 2-week period with subcutaneous GM-CSF (10 µg/kg) or placebo, respectively. CFI was determined by simultaneous measurement of mean aortic pressure (Pao, mm Hg), distal coronary occlusive pressure (Poccl, mm Hg; using intracoronary sensor guidewires), and central venous pressure (CVP, mm Hg): CFI=(Poccl-CVP)/(Pao-CVP). CFI, expressing collateral flow during coronary occlusion relative to normal antegrade flow during vessel patency, changed from 0.21±0.14 to 0.31±0.23 in the GM-CSF group (P<0.05) and from 0.30±0.16 to 0.23±0.11 in the placebo group (P=NS). The treatment-induced difference in CFI was +0.11±0.12 in the GM-CSF group and -0.07±0.12 in the placebo group (P=0.01). ECG signs of myocardial ischemia during coronary balloon occlusion occurred in 9 of 10 patients before and 5 of 10 patients after GM-CSF treatment (P=0.04), whereas they were observed in 5 of 11 patients before and 8 of 11 patients after placebo (P=NS).
Conclusions— This first clinical study investigating the potential of GM-CSF to improve collateral flow in patients with coronary artery disease documents its efficacy in a short-term administration protocol.
Key Words: coronary disease • collateral circulation • growth substances • granulocyte-macrophage colony-stimulating factor
This article has been cited by other articles:
 |
|
 |
|
  J. C. Chappell, J. Song, A. L. Klibanov, and R. J. Price Ultrasonic Microbubble Destruction Stimulates Therapeutic Arteriogenesis Via the CD18-Dependent Recruitment of Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1117 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Kalka and I. Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vascular Medicine, May 1, 2008; 13(2): 157 - 172. [Abstract] [PDF]
|
|
|
|
|
|
H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF]
|
|
|
|
 |
|
 L. O. Jensen, P. Thayssen, J. F. Lassen, H. S. Hansen, H. Kelbaek, A. Junker, K. E. Pedersen, K. N. Hansen, L. R. Krusell, H. E. Botker, et al. Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention Eur. Heart J., August 1, 2007; 28(15): 1820 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grundmann, N. van Royen, G. Pasterkamp, N. Gonzalez, E. J. Tijsma, J. J. Piek, and I. E. Hoefer A New Intra-Arterial DeliveryPlatform for Pro-Arteriogenic Compounds to Stimulate Collateral Artery Growth Via Transforming Growth Factor-{beta}1 Release J. Am. Coll. Cardiol., July 24, 2007; 50(4): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lu, X. Xu, M. Zhang, R. Cao, E. Brakenhielm, C. Li, H. Lin, G. Yao, H. Sun, L. Qi, et al. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs PNAS, July 17, 2007; 104(29): 12140 - 12145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Perera, G. S. Kanaganayagam, M. Saha, R. Rashid, M. S. Marber, and S. R. Redwood Coronary Collaterals Remain Recruitable After Percutaneous Intervention Circulation, April 17, 2007; 115(15): 2015 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. C. Schneider, L. Schilling, H. Schroeck, C. T. Nebe, P. Vajkoczy, and J. Woitzik Granulocyte-Macrophage Colony-Stimulating Factor-Induced Vessel Growth Restores Cerebral Blood Supply After Bilateral Carotid Artery Occlusion Stroke, April 1, 2007; 38(4): 1320 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-L. Ang, L. Takura Shenje, L. Srinivasan, and M. Galinanes Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope. Ann. Thorac. Surg., October 1, 2006; 82(4): 1549 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J.M. Loomans, H. Wan, R. de Crom, R. van Haperen, H.C. de Boer, P.J.M. Leenen, H.A. Drexhage, T.J. Rabelink, A.J. van Zonneveld, and F.J.T. Staal Angiogenic Murine Endothelial Progenitor Cells Are Derived From a Myeloid Bone Marrow Fraction and Can Be Identified by Endothelial NO Synthase Expression Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1760 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Dormond and J. C. Madsen Invited commentary. Ann. Thorac. Surg., May 1, 2006; 81(5): 1736 - 1737. [Full Text] [PDF]
|
|
|
|
 |
|
 Additional Information JAMA, March 15, 2006; 295(11): E7 - E14. [Full Text] [PDF]
|
|
|
|
|
|
R. Vogel, R. Zbinden, A. Indermuhle, S. Windecker, B. Meier, and C. Seiler Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment Eur. Heart J., January 2, 2006; 27(2): 157 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H.J. Pijls Assessment of the collateral circulation of the heart Eur. Heart J., January 2, 2006; 27(2): 123 - 124. [Full Text] [PDF]
|
|
|
|
|
|
E. D. de Muinck and M. Simons Calling on Reserves: Granulocyte Colony Stimulating Growth Factor in Cardiac Repair Circulation, November 15, 2005; 112(20): 3033 - 3035. [Full Text] [PDF]
|
|
|
|
|
|
S. Zbinden, R. Zbinden, P. Meier, S. Windecker, and C. Seiler Safety and Efficacy of Subcutaneous-Only Granulocyte-Macrophage Colony-Stimulating Factor for Collateral Growth Promotion in Patients With Coronary Artery Disease J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1636 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hill, M. A. Syed, A. E. Arai, T. M. Powell, J. D. Paul, G. Zalos, E. J. Read, H. M. Khuu, S. F. Leitman, M. Horne, et al. Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients With Coronary Artery Disease J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1643 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Wilson and T. D. Henry Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor: Double-Edged Swords J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1649 - 1650. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grundmann, I. Hoefer, S. Ulusans, N. van Royen, S. H. Schirmer, C. K. Ozaki, C. Bode, J. J. Piek, and I. Buschmann Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1497 - H1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lenk, V. Adams, P. Lurz, S. Erbs, A. Linke, S. Gielen, A. Schmidt, D. Scheinert, G. Biamino, F. Emmrich, et al. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia Eur. Heart J., September 2, 2005; 26(18): 1903 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Huang, S. Li, M. Han, Z. Xiao, R. Yang, and Z. C. Han Autologous Transplantation of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes Diabetes Care, September 1, 2005; 28(9): 2155 - 2160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Royen, S. H. Schirmer, B. Atasever, C. Y.H. Behrens, D. Ubbink, E. E. Buschmann, M. Voskuil, P. Bot, I. Hoefer, R. O. Schlingemann, et al. START Trial: A Pilot Study on STimulation of ARTeriogenesis Using Subcutaneous Application of Granulocyte-Macrophage Colony-Stimulating Factor as a New Treatment for Peripheral Vascular Disease Circulation, August 16, 2005; 112(7): 1040 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Haider and M. Ashraf Bone marrow stem cell transplantation for cardiac repair Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Annex and M. Simons Growth factor-induced therapeutic angiogenesis in the heart: protein therapy Cardiovasc Res, February 15, 2005; 65(3): 649 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Song, P. S. Cottler, A. L. Klibanov, S. Kaul, and R. J. Price Microvascular remodeling and accelerated hyperemia blood flow restoration in arterially occluded skeletal muscle exposed to ultrasonic microbubble destruction Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2754 - H2761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pompilio, A. Cannata, F. Peccatori, F. Bertolini, A. Nascimbene, M. C. Capogrossi, and P. Biglioli Autologous Peripheral Blood Stem Cell Transplantation for Myocardial Regeneration: A Novel Strategy for Cell Collection and Surgical Injection Ann. Thorac. Surg., November 1, 2004; 78(5): 1808 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maekawa, T. Anzai, T. Yoshikawa, Y. Sugano, K. Mahara, T. Kohno, T. Takahashi, and S. Ogawa Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1510 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y.W. Lew Mobilizing cells to the injured myocardium: A novel rescue strategy or an unwelcome intrusion? J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1521 - 1522. [Full Text] [PDF]
|
|
|
|
 |
|
 H T Hassan and M El-Sheemy Adult bone-marrow stem cells and their potential in medicine J R Soc Med, October 1, 2004; 97(10): 465 - 471. [Full Text] [PDF]
|
|
|
|
|
|
A. Kawamoto, T. Murayama, K. Kusano, M. Ii, T. Tkebuchava, S. Shintani, A. Iwakura, I. Johnson, P. von Samson, A. Hanley, et al. Synergistic Effect of Bone Marrow Mobilization and Vascular Endothelial Growth Factor-2 Gene Therapy in Myocardial Ischemia Circulation, September 14, 2004; 110(11): 1398 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Heil and W. Schaper Influence of Mechanical, Cellular, and Molecular Factors on Collateral Artery Growth (Arteriogenesis) Circ. Res., September 3, 2004; 95(5): 449 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schneeloch, G. Mies, H.-J. Busch, I. R. Buschmann, and K.-A. Hossmann Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke PNAS, August 24, 2004; 101(34): 12730 - 12735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Zbinden, R Vogel, B Meier, and C Seiler Coronary collateral flow and peripheral blood monocyte concentration in patients treated with granulocyte-macrophage colony stimulating factor Heart, August 1, 2004; 90(8): 945 - 946. [Full Text] [PDF]
|
|
|
|
|
|
P. D. Lambiase, R. J. Edwards, P. Anthopoulos, S. Rahman, Y. G. Meng, C. A. Bucknall, S. R. Redwood, J. D. Pearson, and M. S. Marber Circulating Humoral Factors and Endothelial Progenitor Cells in Patients With Differing Coronary Collateral Support Circulation, June 22, 2004; 109(24): 2986 - 2992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.H. Tayebjee, G.Y.H. Lip, and R.J. MacFadyen Collateralization and the response to obstruction of epicardial coronary arteries QJM, May 1, 2004; 97(5): 259 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Fujita and K Tambara Recent insights into human coronary collateral development Heart, March 1, 2004; 90(3): 246 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ziegelhoeffer, B. Fernandez, S. Kostin, M. Heil, R. Voswinckel, A. Helisch, and W. Schaper Bone Marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature Circ. Res., February 6, 2004; 94(2): 230 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Seiler The human coronary collateral circulation Heart, November 1, 2003; 89(11): 1352 - 1357. [Full Text] [PDF]
|
|
|
|
|
|
I. R. Buschmann, H.-J. Busch, G. Mies, and K.-A. Hossmann Therapeutic Induction of Arteriogenesis in Hypoperfused Rat Brain Via Granulocyte-Macrophage Colony-Stimulating Factor Circulation, August 5, 2003; 108(5): 610 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Royen, J. J Piek, D. A Legemate, W. Schaper, J. Oskam, B. Atasever, M. Voskuil, D. Ubbink, S. H Schirmer, I. Buschmann, et al. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial Vascular Medicine, August 1, 2003; 8(3): 191 - 196. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. Edelberg, M. Xaymardan, S. Rafii, and M. K. Hong Adult Cardiac Stem Cells--Where Do We Go from Here? Sci. Aging Knowl. Environ., July 2, 2003; 2003(26): pe17 - 17. [Abstract] [Full Text]
|
|
|
|
|
|
P. E. Szmitko, P. W.M. Fedak, R. D. Weisel, D. J. Stewart, M. J.B. Kutryk, and S. Verma Endothelial Progenitor Cells: New Hope for a Broken Heart Circulation, June 24, 2003; 107(24): 3093 - 3100. [Full Text] [PDF]
|
|
|
|
|
|
G. S. Werner, M. Ferrari, S. Heinke, F. Kuethe, R. Surber, B. M. Richartz, and H. R. Figulla Angiographic Assessment of Collateral Connections in Comparison With Invasively Determined Collateral Function in Chronic Coronary Occlusions Circulation, April 22, 2003; 107(15): 1972 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Royen, I. Hoefer, M. Bottinger, J. Hua, S. Grundmann, M. Voskuil, C. Bode, W. Schaper, I. Buschmann, and J.J. Piek Local Monocyte Chemoattractant Protein-1 Therapy Increases Collateral Artery Formation in Apolipoprotein E-Deficient Mice but Induces Systemic Monocytic CD11b Expression, Neointimal Formation, and Plaque Progression Circ. Res., February 7, 2003; 92(2): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Orlic, J. M. Hill, and A. E. Arai Stem Cells for Myocardial Regeneration Circ. Res., December 13, 2002; 91(12): 1092 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Heil, T. Ziegelhoeffer, F. Pipp, S. Kostin, S. Martin, M. Clauss, and W. Schaper Blood monocyte concentration is critical for enhancement of collateral artery growth Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2411 - H2419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Werner, C. Seiler, T. Pohl, K. Wustmann, D. Hutter, P.-A. Nicolet, S. Windecker, F. R. Eberli, and B. Meier Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease * Response Circulation, May 14, 2002; 105 (19): e175 - e175. [Full Text] [PDF]
|
|
|
|
|
|
T. Pohl, C. Seiler, M. Billinger, E. Herren, K. Wustmann, H. Mehta, S. Windecker, F. R. Eberli, and B. Meier Frequency distribution of collateral flow and factors influencing collateral channel development: Functional collateral channel measurement in 450 patients with coronary artery disease J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1872 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Schaper Therapeutic Arteriogenesis Has Arrived Circulation, October 23, 2001; 104(17): 1994 - 1995. [Full Text] [PDF]
|
|